The steroid hormone aldosterone maintains sodium homeostasis and is therefore important in the control of blood volume and pressure. 
] e ), the prime physiologic regulators of aldosterone secretion from adrenal glomerulosa cells, activate phospholipase D (PLD) in these cells. The role of Ca 2C in the activation by these agents is unknown, although nitrendipine, a voltage-dependent Ca 2C channel antagonist, does not inhibit AngII-elicited PLD activation, despite the fact that this compound blocked elevated [K C ] e -stimulated PLD activity. PLD activation triggered by AngII was also unaffected by the T-type calcium channel inhibitor nickel. Nevertheless, Ca 2C influx was required for AngII-induced PLD activation in both primary cultures of bovine adrenal glomerulosa cells and a glomerulosa cell model, the NCI H295R adrenocortical carcinoma cell line. The involvement of store-operated Ca 2C (SOC) influx and Ca 2C release-activated Ca 2C (CRAC) influx pathways in PLD activation was investigated using thapsigargin, an endoplasmic reticulum Ca 2C pump inhibitor that empties the store to induce SOC influx, and the SOC inhibitor YM-58483 (BTP2), as well as a CRAC inhibitor, tyrphostin A9. In bovine glomerulosa cells, tyrphostin A9 inhibited AngII-induced PLD activation without affecting elevated [K
Introduction
The steroid hormone aldosterone controls sodium homeostasis and thus blood volume and pressure. Aldosterone is secreted from glomerulosa cells in the adrenal cortex in response to two major regulators, angiotensin II (AngII) and elevated extracellular potassium concentration ([K C ] e ). AngII induces aldosterone secretion by binding to the AngII type 1 receptor, which is coupled to phosphatidylinositol 4,5-bisphosphate hydrolysis resulting in the production of inositol 1,4,5-trisphosphate and diacylglycerol (DAG; reviewed in Barrett et al. (1989) , Foster (2004) , Spät & Hunyady (2004) and Rainey et al. (2008) ). These second messengers, in turn, increase cytosolic calcium (Ca 2C ) levels (to activate Ca 2C /calmodulin-dependent protein kinases) and stimulate protein kinase C (PKC) respectively (reviewed in Rainey et al. (2008) ). Elevated [K C ] e , on the other hand, triggers glomerulosa cell depolarization, which opens voltage-dependent Ca 2C channels and also increases cytosolic Ca 2C levels (reviewed in Rainey et al. (2008) ). We previously showed that not only AngII but also elevated [K C ] e activates phospholipase D (PLD; Betancourt-Calle et al. 2001) , the activity of which can produce lipid messengers including phosphatidic acid and DAG (reviewed in Bollag & Zheng (2005) ). Furthermore, inhibition of PLD-mediated signal generation inhibits both AngII-and elevated [K C ] e -elicited aldosterone secretion (Betancourt-Calle et al. 2001 , Bollag et al. 2002 , Zheng & Bollag 2003 , suggesting the importance of this signaling enzyme to steroid hormone production. Therefore, it is important to understand the mechanisms that regulate PLD activity in response to AngII and elevated [K C ] e . The ability of both AngII and elevated [K C ] e to activate PLD suggests a possible involvement of Ca 2C in the process, since an increase in the cytosolic Ca 2C concentration is common to these two agonists (reviewed in Rainey et al. (2008) ). However, the role of Ca 2C in PLD activation in other systems is unclear, and, in fact, Exton (1999) indicated that 'direct control of the enzyme by physiological changes in cytosolic Ca 2C seems unlikely'. Investigators have shown an ability of cytosolic Ca 2C concentration to modulate PLD activity, with chelation of intracellular Ca 2C inhibiting PLD activation in response to some agonists and Ca 2C ionophores increasing enzyme activity (reviewed in Exton (1999) Exton (1999) ). On the other hand, in primary bovine glomerulosa cells, the inability of the Ca 2C ionophores ionomycin or A23187 to activate PLD (Bollag et al. 2002) suggests that changes in cytosolic Ca 2C levels alone are not sufficient to stimulate PLD activity. Furthermore, the fact that elevated [K C ] e , which functions through voltage-dependent Ca 2C channels, activates PLD in bovine adrenal glomerulosa cells (Betancourt-Calle et al. 2001) suggests a possible involvement of Ca 2C influx in regulating PLD activity. However, the lack of inhibition of AngIIinduced PLD activation by nitrendipine (Bollag et al. 2002) , a voltage-dependent Ca 2C channel antagonist, at a dose that inhibits aldosterone secretion (Kojima et al. 1985b) , supports the idea that only certain Ca 2C pathways may be important in stimulating PLD in response to particular agonists.
The objectives of this study were to determine the role of Ca 2C influx pathways in activating PLD in response to AngII as well as to elevated [K C ] e in primary cultures of bovine adrenal glomerulosa cells. In addition, we sought to compare the effects of modulating Ca 2C influx on PLD activation and acute aldosterone secretion in this bovine system with the responses observed in the NCI H295R human adrenocortical carcinoma cell line.
Materials and Methods

Materials
The following were obtained from Sigma: phorbol 12-myristate 13-acetate (PMA), AngII, and 22(R)-hydroxycholesterol. UltroSer G was acquired from BioSepra (Cergy St Christophe, France) under a permit from the US Department of Agriculture. [ 3 H]Oleic acid was purchased from Dupont NEN (Boston, MA, USA). Silica gel 60 thin-layer chromatography plates with concentrating zones were obtained from EM Science through VWR (West Chester, PA, USA) and phosphatidylethanol (PEt) and phosphatidic acid standards from Avanti Polar Lipids (Alabaster, AL, USA). ITSCpremix (12 . 5 mg insulin, 12 . 5 mg transferrin, 12 . 5 mg selenous acid, 10 . 7 mg linoleic acid, and 2 . 5 mg BSA) was purchased from BD Biosciences (San Jose, CA, USA). Thapsigargin, YM-58483 (BTP2) and tyrphostin A9 were obtained from Calbiochem (San Diego, CA, USA).
Primary culture of bovine adrenal glomerulosa cells
Bovine adrenal glomerulosa cells were prepared and cultured as described in Bollag et al. (2007) . Briefly, the glomerulosa layer was dissected from adrenal glands of near-term fetal calves obtained from a local meat-packing plant. Glomerulosa cells were released from tissue slices by enzymatic and mechanical means and collected by centrifugation. Cells were plated in Primaria plates (BD Falcon, Franklin Lakes, NJ, USA) overnight in a medium consisting of DMEM/Ham's F12 (1:1 vol:vol) containing 10% horse serum, 2% fetal bovine serum, 100 mM ascorbate, 1 . 2 mM a-tocopherol, 0 . 05 mM Na 2 SeO 3 , 50 mM butylated hydroxyanisole, 5 mM metyrapone, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0 . 25 mg/ml fungizone. The cells were then incubated for 20-24 h in serum-free DMEM/Ham's F12 (containing 0 . 2% BSA, 100 mM ascorbate, 1 . 2 mM a-tocopherol, 0 . 05 mM Na 2 SeO 3 , 50 mM butylated hydroxyanisole, 5 mM metyrapone, and antibiotics) prior to experimentation.
Culture of NCI H295R human adrenocortical carcinoma cells NCI H295R cells were cultured as described in Zheng & Bollag (2003) . Briefly, cells were grown in DMEM/Ham's F12 (1:1 vol:vol) containing 1% ITSC(12 . 5 mg insulin, 12 . 5 mg transferrin, 12 . 5 mg selenous acid, 10 . 7 mg linoleic acid, and 2 . 5 mg BSA from BD Biosciences), 2% UltroSer G, 100 U/ml penicillin,100 mg/ml streptomycin, and 0 . 25 mg/ml fungizone, to w70-75% confluence. The cells were then incubated for 20-24 h in serum-free medium (consisting of DMEM/Ham's F12 containing 0 . 01% BSA and antibiotics) prior to experimentation.
Measurement of aldosterone secretion
Cells were incubated for the indicated times with the appropriate agents in bicarbonate-buffered Kreb's Ringer containing 2 . 5 mM sodium acetate (KRB C ). Aldosterone release into the medium was then assayed using a RIA kit from Diagnostic Products Corporation (Los Angeles, CA, USA) as described in Bollag et al. (2007) ] e was performed by iso-osmotic substitution. Phospholipids were extracted with chloroform/methanol and separated by thin-layer chromatography, and radiolabeled PEt was quantified by liquid scintillation spectrometry as described in Bollag (1998) .
Statistical analysis
Experiments were performed a minimum of three times in duplicate or triplicate. Data were analyzed by ANOVA with a Student-Newmann-Keuls post hoc test using the computer program Instat (Graphpad, San Diego, CA, USA), except where indicated in the figure legends. A P value%0 . 05 was considered significant.
Results
We have previously shown that elevated [K C ] e stimulates PLD activity (Betancourt-Calle et al. 2001) . Because of the importance of PLD to sustained aldosterone secretion (Bollag et al. 2002 , Zheng & Bollag 2003 , we wanted to characterize the mechanism by which elevated [K C ] e and AngII activate PLD. We previously showed that the voltage-dependent Ca 2C channel antagonist, nitrendipine, does not alter AngIIinduced PLD activation (Bollag et al. 2002) , even at a concentration (1 mM) reported to inhibit both transient, or T-type, and long-lasting, or L-type, Ca 2C channels (Barrett et al. 1995) . (Bollag et al. 1990 (Bollag et al. , 1992 . Nitrendipine (1 mM) completely abolished elevated [K C ] e -induced changes in PLD activity ( Fig. 1), although it had no effect on either basal ( Fig. 1 ; Bollag et al. 2002) or AngII-stimulated PLD activity (Bollag et al. 2002) ] e , we used the T-type channel inhibitor, nickel, at a dose reported to inhibit T-type Ca 2C influx, specifically through a-1H T-type Ca 2C channels (Schrier et al. 2001) . We observed no effect of 50 mM nickel on PLD activity either under basal conditions or upon stimulation with AngII ( Fig. 2A) . On the other hand, elevated [K C ] e -stimulated PLD activity, and nickel returned this increase to a level not significantly different from the control value, causing an approximate 43% inhibition (Fig. 2B) release-activated Ca 2C (CRAC) channels. To test the role of SOC influx in AngII-and elevated extracellular [K C ] e -induced PLD activation, we determined the effects on PLD activity of thapsigargin, a pharmacologic agent that inhibits the sarcoplasmic/endoplasmic reticulum Ca 2C pump to release Ca 2C from these stores and activate SOC influx (reviewed in Spät & Hunyady (2004) ). We selected a dose of thapsigargin (2 mM) that has previously been shown to increase SOC Ca 2C influx in primary cultures of bovine adrenal glomerulosa cells (Burnay et al. 1998 , Aptel et al. 1999 . We found that thapsigargin had little effect on AngII-induced PLD activation (Fig. 4A ) in primary bovine adrenal glomerulosa cells, whereas this compound stimulated elevated [K C ] e -elicited PLD activity (Fig. 4B) . Interestingly, these results were mirrored by the effects of thapsigargin on aldosterone secretion in that the compound had little effect on AngII-induced steroidogenesis but augmented elevated [K C ] e -elicited aldosterone secretion (Fig. 5A ), consistent with a previous report in bovine adrenal glomerulosa cells (Burnay et al. 1994) . In addition, thapsigargin enhanced the aldosterone secretory response to the phorbol ester, PMA, which mimics DAG action in primary bovine adrenal glomerulosa cells (Fig. 5B ). This latter result is consistent with the proposed requirement for two signals mediating sustained aldosterone secretion: a DAG second messenger and a Ca 2C influx signaling pathway (reviewed in Rasmussen et al. (1995) ). To further examine the role of SOC in AngII-and elevated [K C ] e -induced PLD activation, we treated cells with these agonists in the presence and absence of the SOC inhibitor, YM-58483, also known as BTP2. We found that BTP2 had no effect on PLD activation elicited in response to AngII (Fig. 6A) . However, this agent actually seemed to increase elevated [K C ] e -induced PLD activation, converting a nonsignificant response to elevated [K C ] e alone to a significant increase in the presence of BTP2 (Fig. 6B ). This result suggests that whereas SOC can enhance the activation of PLD, i.e. in conjunction with elevated [K C ] e , it is not necessary for PLD activation in response to either agonist.
The archetypical SOC pathway is CRAC, mediated by Stim and Orai proteins (reviewed in Potier & Trebak (2008) ). To examine the possible role of CRAC channels in AngIIinduced PLD activation, we determined the effect of the CRAC channel inhibitor, tyrphostin A9 (Denys et al. 2004 ) on this signaling event. As shown in Fig. 7A , we found that tyrphostin A9 inhibited AngII-elicited PLD activation in primary bovine adrenal glomerulosa cells, without affecting basal PLD activity. By contrast, tyrphostin A9 had no effect on elevated [K C ] e -induced PLD activation in the primary glomerulosa cells (Fig. 7B) . In experiments to determine the ability of tyrphostin A9 to modulate the aldosterone secretory response, we found that tyrphostin A9 completely blocked AngII-and elevated [K C ] e -induced aldosterone secretion (data not shown). However, we also observed that tyrphostin A9 significantly inhibited the ability of 22(R)-hydroxycholesterol to trigger steroidogenesis (Fig. 7C) . Because 22(R)-hydroxycholesterol can directly enter mitochondria to access the rate-limiting enzyme of aldosterone ] e -elicited PLD activity indicates that the inhibitor is not simply cytotoxic and suggests instead that the compound inhibits an enzyme in the aldosterone synthetic pathway.
We have previously shown that AngII activates PLD in H295R cells (Zheng & Bollag 2003) , as in primary cultures of bovine adrenal glomerulosa cells (Bollag et al. 1990) , and that this activity mediates, at least in part, the ability of AngII to induce steroidogenesis (Zheng & Bollag 2003) , as in the bovine cells (Bollag et al. 2002) . However, in contrast to results in primary bovine adrenal glomerulosa cells, in which AngII-induced PLD activation is sustained ( Jung et al. 1998) , in H295R cells AngII elicits only transient PLD activation (Zheng & Bollag 2003) . We wished to examine whether H295R cells exhibited other differences in the mechanism of PLD activation in response to aldosterone agonists. Initially, we examined the Ca 2C dependence of AngII-induced PLD activation in the H295R cells. Similar to the primary bovine adrenal glomerulosa cells (Fig. 2) , a lack of extracellular Ca 2C also inhibited AngII-elicited PLD activation in H295R cells (Fig. 8) . Importantly, however, we were unable to detect PLD activation in response to elevated [K C ] e in the H295R cells under a variety of conditions (data not shown), including at different time points and following pretreatment with aldosterone, reported to increase T-type channel expression (Lesouhaitier et al. 2001) .
On the other hand and in contrast to the primary bovine adrenal glomerulosa cells (Fig. 4) , thapsigargin enhanced AngII-induced PLD activation in the H295R cells (Fig. 9A) . The effects on AngII-induced PLD activation in the H295R cells were not accompanied by comparable changes in aldosterone secretion, as thapsigargin had little or no effect on AngII-induced aldosterone production (Fig. 9B ), although this result was similar to that observed in the primary bovine adrenal glomerulosa cells (Fig. 4) . However, in contrast to the bovine cells, thapsigargin did not alter elevated [K C ] e -elicited steroidogenesis in the H295R cells (Fig. 9B) . Taken together, these results suggest that while similarities exist between the mechanisms of AngII-induced PLD activation in primary bovine adrenal glomerulosa cells versus the human adrenocortical carcinoma H295R cells, there are also distinct differences. However, which AngII-elicited PLD activation scenario is most similar to the situation occurring in vivo, i.e. in human patients, is at present unknown.
Discussion
We have previously shown that PLD-mediated signal generation is required for maximal AngII-induced secretion in both primary cultures of bovine adrenal glomerulosa cells and the NCI H295R human adrenocortical carcinoma cell line (Bollag et al. 2002 , Zheng & Bollag 2003 Rainey et al. (2008) ). Perhaps a bit more unexpected is the observation that AngII-induced PLD activity also requires Ca 2C influx, although this Ca 2C influx is not mediated by voltage-dependent Ca 2C channels, as neither nitrendipine nor nickel has an inhibitory effect on AngII-induced PLD activation (Bollag et al. 2002) . However, removal of extracellular Ca 2C inhibits AngII-elicited PLD activation in both primary bovine adrenal glomerulosa cells (Fig. 3 ) and H295R cells (Fig. 8) , suggesting that Ca 2C influx plays some H QIN and others . Ca 2C and phospholipase D in glomerulosa cellsrole in PLD activation. Nevertheless, the importance of Ca 2C in regulating PLD activity was somewhat unanticipated since we previously found no effect of Ca 2C ionophores on PLD activity in primary glomerulosa cells nor inhibition of AngII-induced enzyme activation by a voltage-dependent Ca 2C channel antagonist (Bollag et al. 2002) . On the other hand, we have previously shown that in both cell models, PKC appears to mediate, at least in part, PLD activation in response to AngII (Bollag et al. 2002 , Zheng & Bollag 2003 , as has been reported for other cell systems (reviewed in Frohman & Morris (1996) and Exton (1998) ). Thus, exposure to PMA is sufficient to induce PLD activation in both bovine and H295R cells (Bollag et al. 2002 , Zheng & Bollag 2003 , and PKC inhibitors reduce AngII-stimulated PLD activity (Zheng & Bollag 2003) . Thus, the requirement for Ca 2C influx may be related to activation of PKC, presumably a classical, Ca 2C -dependent PKC isoenzyme, as suggested by the results of Kojima et al. (1994) who demonstrated that Ca 2C can, indeed, regulate PKC activity. Although voltage-dependent Ca 2C channels do not appear to be involved in AngII-stimulated PLD activation (Bollag et al. 2002) , AngII also increases Ca 2C influx through other pathways, such as SOC and CRAC (reviewed in Spät & Hunyady (2004) ). Stimulation of SOC by thapsigargin has no effect alone or together with AngII on PLD activation in primary bovine adrenal glomerulosa cells (Fig. 3) . We also observed no effect of thapsigargin on AngII-elicited aldosterone secretion, in contrast to a previous report in rat adrenal glomerulosa cells (Hajnoczky et al. 1991) . The reason for this disparity is unclear but may be related to the species and/or the use of submaximal concentrations of AngII and thapsigargin in the rat cells (Hajnoczky et al. 1991) . Nevertheless, the 2 mM thapsigargin dose used herein was sufficient to enhance the elevated [K C ] e -stimulated PLD Supernatants were collected and assayed for aldosterone secretion by RIA. Values represent the meansGS.E.M., expressed as the ng aldosterone/ml per 60 min, of three separate experiments; *P!0 . 03 versus 22(R)-hydroxycholesterol alone, as determined using an unpaired Student's t-test. Note that 22(R)-hydroxycholesterol induced a significant, w11 000-fold increase over the control aldosterone secretory value. activity and aldosterone secretory rate (Fig. 4) , indicating its efficacy in promoting emptying of the intracellular Ca 2C store, as has been previously demonstrated in these same cells (Burnay et al. 1998 , Aptel et al. 1999 . On the other hand, however, thapsigargin was able to enhance AngII's activation of PLD in H295R cells (Fig. 9) . It is not clear why there is the disparity between the two cell types, although we have previously reported that AngII induces a transient PLD activation in H295R cells (Zheng & Bollag 2003 ) but a sustained activity in bovine adrenal glomerulosa cells (Jung et al. 1998) . Similarly, Bird et al. (1993) have shown that the production of inositol bis-and trisphosphates in response to AngII in the H295R cells is also transient, whereas in bovine adrenal glomerulosa cells AngII elicits a sustained phosphoinositide hydrolysis response (Kojima et al. 1984) . These data suggest that phosphoinositide-specific phospholipase C is only transiently activated in H295R cells by AngII, such that over time the endoplasmic reticulum Ca 2C pool might be expected to refill upon extinction of the transient signal, thereby terminating SOC. Thus, thapsigargin, by prolonging SOC influx could enhance PLD activation (Fig. 9A ) in response to AngII in the H295R cells, without affecting these parameters in primary bovine adrenal glomerulosa cells (Fig. 5) , which exhibit sustained AngII-elicited phospholipase C activation and therefore maintained (i.e. already maximal) SOC. However, despite its enhancement of AngII-induced PLD activation in H295R cells, thapsigargin did not alter AngII-(or elevated [K C ] e -) stimulated aldosterone secretion in these cells (Fig. 9B) . Furthermore, the SOC inhibitor BTP2 (YM-5848) had no effect on AngII-induced PLD activation and appeared to increase that elicited by elevated [K C ] e (Fig. 6) , suggesting that Ca 2C influx mediated by SOC is not necessary for PLD activation in response to either agonist (Fig. 6) .
SOC Ca 2C influx occurs through a pathway exhibiting heterogeneous characteristics, with BTP2 reported to inhibit transient receptor potential (TRP) channels, with a halfmaximal inhibitory concentration of 0 . 1-0 . 3 mM (He et al. 2005) . On the other hand, CRAC represents an archetypical SOC (reviewed in Potier & Trebak (2008) ). Based on our results, CRAC may be a key AngII-induced Ca 2C influx pathway involved in regulating PLD activation in primary bovine adrenal glomerulosa cells. Thus, a CRAC inhibitor, tyrphostin A9 (Denys et al. 2004) , inhibited AngII-stimulated PLD activity but had no effect on the basal or elevated [K C ] einduced value ( Fig. 7A and B) . Tyrphostin A9 has also been reported to inhibit platelet-derived growth factor receptor tyrosine kinase activity (Marhaba et al. 1996) ; thus, the possibility remains that the effects of this compound on AngII-induced PLD activation may be related to inhibition of tyrosine kinase. However, in H295R cells, we were previously unable to detect an effect of the general tyrosine kinase inhibitor, genistein (or the Janus kinase inhibitor AG490 or Src kinase inhibitor PP2), on AngII-stimulated PLD activity (Zheng & Bollag 2003) , suggesting the likelihood that tyrphostin A9's inhibition of CRAC mediates the inhibition of PLD activation in response to AngII. Unfortunately, it was not possible to determine whether CRAC was important in AngII-elicited steroidogenesis. Although tyrphostin A9 completely inhibited AngII-induced aldosterone secretion, as well as that elicited in response to elevated [K C ] e (data not shown), it also inhibited secretion in response to 22(R)-hydroxycholesterol (Fig. 7C) , indicating either effects on cell health or on one or more aldosterone biosynthetic enzymes. However, the inability of tyrphostin A9 to alter basal or elevated [K C ] e -stimulated PLD activity (Fig. 6) suggests that cytotoxicity was not responsible for the inhibition. An ability of inhibitors to affect aldosterone biosynthetic enzymes is not without precedent, as Rainey et al. have demonstrated that genistein inhibits 3b-hydroxysteroid dehydrogenase (Sirianni et al. 2001) .
As expected, in primary bovine adrenal glomerulosa cells, elevated [K C ] e -induced PLD activation was dependent on voltage-dependent Ca 2C channels (Fig. 1) . Interestingly, SOC also appeared to stimulate elevated [K C ] e -elicited PLD activation and aldosterone secretion in bovine adrenal glomerulosa cells, as shown by the ability of thapsigargin to stimulate these processes (Figs 4 and 5) . There is some controversy as to whether elevated [K C ] e triggers phosphoinositide hydrolysis (Hunyady et al. 1982 , Kojima et al. 1985a , Underwood et al. 1988 , Ganguly et al. 1990 , Hajnoczky et al. 1992 , Betancourt-Calle et al. 2001 . Our data, however, would suggest that if it does so, elevated [K C ] e is not particularly effective at inducing SOC, since thapsigargin can augment the effects of this ion on aldosterone secretion in primary bovine adrenal glomerulosa (Fig. 5) 
